跳至主要内容
临床试验/DRKS00023896
DRKS00023896
已完成
不适用

Validation study for the predictor model and clinical score SACOV-19 in COVID-19: PREDICT-COVID - PREDICT-COVID

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 124 人2022年12月20日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
U07.1
发起方
Klinikum der Universität München, Campus Großhadern
入组人数
124
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2022年12月20日
结束日期
2022年4月30日
最后更新
去年
研究类型
Observational
性别
All

研究者

发起方
Klinikum der Universität München, Campus Großhadern

入排标准

入选标准

  • Uncomplicated SARS\-CoV\-2 infection with PCR detection within the last 72 hours.

排除标准

  • Complicated or more severe COVID\-19, reconvalescence stage

结局指标

主要结局

未指定

相似试验

已完成
不适用
Validation study of the prognostic and predictive value of TP53 signature for breast cancer Collateral research
JPRN-UMIN000042055Japan Agency for Medical Research and Development107
已完成
不适用
Prospective validation of a predictive model for pathologic complete response after chemoradiotherapy in rectal cancer: A prognostic studycancer of the rectum/rectumcancer1000211210017991
NL-OMON33076MAASTRO clinic60
进行中(未招募)
1 期
Assessment of a predictive response model for romiplostim in patients with low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia - the EUROPE-trialPatients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopeniaMedDRA version: 18.1Level: LLTClassification code 10068361Term: MDSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2013-004328-12-FRGMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH90
进行中(未招募)
1 期
Assessment of a predictive response model for romiplostim in patients with low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia - the EUROPE-trialPatients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopeniaMedDRA version: 20.0Level: LLTClassification code 10068361Term: MDSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2013-004328-12-DEGMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH75
已完成
不适用
Prediction of Risks in Early onset Pre-eclampsia (PREP)Early onset pre-eclampsiaPregnancy and ChildbirthPre-eclampsia
ISRCTN40384046Queen Mary University of London (UK)500